19 July 2017: ReNeuron Group plc (the “Company”) (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announces that Dr Paul Harper, a non-executive director of the business since the Company’s flotation on AIM in 2005, will step down from the Board at the next Annual General Meeting of the Company.